Manulife (Manufacturers Life Insurance)
SRPT icon

Manulife (Manufacturers Life Insurance)’s Sarepta Therapeutics SRPT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$927K Buy
51,565
+30,110
+140% +$569K ﹤0.01% 1996
2026
Q1 		$467K Buy
21,455
+2,661
+14% +$51.5K ﹤0.01% 2188
2025
Q4 		$404K Sell
18,794
-63
-0.3% -$1.33K ﹤0.01% 2263
2025
Q3 		$363K Sell
18,857
-54,797
-74% -$977K ﹤0.01% 2326
2025
Q2 		$1.26M Sell
73,654
-123,966
-63% -$5.29M ﹤0.01% 1715
2025
Q1 		$12.6M Buy
197,620
+3,968
+2% +$418K 0.01% 742
2024
Q4 		$23.5M Buy
193,652
+118,874
+159% +$14.6M 0.02% 585
2024
Q3 		$9.34M Sell
74,778
-14,747
-16% -$2.04M 0.01% 918
2024
Q2 		$14.1M Buy
89,525
+49,137
+122% +$6.31M 0.01% 715
2024
Q1 		$5.23M Sell
40,388
-12,932
-24% -$1.58M ﹤0.01% 1177
2023
Q4 		$5.14M Buy
53,320
+4,148
+8% +$398K ﹤0.01% 1159
2023
Q3 		$5.96M Buy
49,172
+13,724
+39% +$1.55M ﹤0.01% 1031
2023
Q2 		$4.06M Sell
35,448
-8,671
-20% -$1.12M ﹤0.01% 1187
2023
Q1 		$6.08M Buy
44,119
+14,702
+50% +$1.91M ﹤0.01% 991
2022
Q4 		$3.75M Sell
29,417
-1,636
-5% -$190K ﹤0.01% 1191
2022
Q3 		$3.41M Sell
31,053
-2,240
-7% -$226K ﹤0.01% 1217
2022
Q2 		$2.56M Buy
33,293
+4,340
+15% +$319K ﹤0.01% 1357
2022
Q1 		$2.27M Buy
+28,953
New +$2.22M ﹤0.01% 1466
2021
Q1 		– Sell
-1,560
Closed -$266K – 3123
2020
Q4 		$266K Hold
1,560
– – ﹤0.01% 2588
2020
Q3 		$219K Hold
1,560
– – ﹤0.01% 2508
2020
Q2 		$254K Buy
+1,560
New +$212K ﹤0.01% 2359
2020
Q1 		– Sell
-1,866
Closed -$241K – 2892
2019
Q4 		$241K Buy
+1,866
New +$188K ﹤0.01% 2473
2019
Q3 		– Sell
-1,819
Closed -$276K – 2917
2019
Q2 		$276K Buy
+1,819
New +$221K ﹤0.01% 2411
2018
Q4 		– Sell
-1,615
Closed -$261K – 2802
2018
Q3 		$261K Sell
1,615
-220
-12% -$30.1K ﹤0.01% 2602
2018
Q2 		$242K Sell
1,835
-43,422
-96% -$4.09M ﹤0.01% 2968
2018
Q1 		$3.35M Sell
45,257
-1,210
-3% -$80.7K ﹤0.01% 1354
2017
Q4 		$2.58M Buy
46,467
+1,604
+4% +$85K ﹤0.01% 1400
2017
Q3 		$2.04M Buy
44,863
+4,675
+12% +$187K ﹤0.01% 1429
2017
Q2 		$1.35M Buy
40,188
+1,435
+4% +$46.7K ﹤0.01% 1624
2017
Q1 		$1.15M Buy
38,753
+4,676
+14% +$145K ﹤0.01% 1667
2016
Q4 		$935K Buy
34,077
+4,802
+16% +$193K ﹤0.01% 1703
2016
Q3 		$1.8M Sell
29,275
-5
-0% -$151 ﹤0.01% 1406
2016
Q2 		$558K Sell
29,280
-445
-1% -$8.24K ﹤0.01% 1956
2016
Q1 		$573K Buy
29,725
+2,454
+9% +$42.9K ﹤0.01% 1917
2015
Q4 		$1.05M Buy
27,271
+274
+1% +$8.88K ﹤0.01% 1607
2015
Q3 		$867K Buy
26,997
+427
+2% +$14.5K ﹤0.01% 1677
2015
Q2 		$809K Sell
26,570
-1,072
-4% -$21.9K ﹤0.01% 1809
2015
Q1 		$367K Buy
27,642
+1,095
+4% +$14.6K ﹤0.01% 2281
2014
Q4 		$384K Sell
26,547
-201
-0.8% -$3.4K ﹤0.01% 2162
2014
Q3 		$564K Buy
26,748
+654
+3% +$14.8K ﹤0.01% 1914
2014
Q2 		$778K Sell
26,094
-2,536
-9% -$80.2K ﹤0.01% 1751
2014
Q1 		$688K Buy
28,630
+2,719
+10% +$69.3K ﹤0.01% 1878
2013
Q4 		$528K Buy
25,911
+1,350
+5% +$40.1K ﹤0.01% 2024
2013
Q3 		$1.16M Sell
24,561
-771
-3% -$29.7K ﹤0.01% 1476
2013
Q2 		$964K Buy
+25,332
New +$906K ﹤0.01% 1491

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s SRPT Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Sarepta Therapeutics (SRPT) stake by 140% in Q2 2026, buying an estimated $569K and bringing the position to 51,565 shares worth $927K. The position accounts for ﹤0.01% of the portfolio, ranked #1996.

Manulife (Manufacturers Life Insurance) first reported a position in SRPT in Q2 2013 and has held it in 45 quarters since. The position peaked at $23.5M in Q4 2024. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 51,565 shares of Sarepta Therapeutics worth $927K as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 30,110 Sarepta Therapeutics shares in Q2 2026, an estimated $569K.
  • Sarepta Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #1996 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 45 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Sarepta Therapeutics position peaked at $23.5M in Q4 2024.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.